Variant · Snv
RAD51C NM_058216.3(RAD51C):c.904+5G>T
CI-VAR-00024553Explore in graph →NM_058216.3:c.904+5G>TClinVar 142762 rs587782702
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 142762 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Breast-ovarian cancer, familial, susceptibility to, 3; Hereditary cancer-predisposing syndrome; Fanconi anemia complementation group O; Hereditary site-specific ovarian cancer syndrome; Breast and/or ovarian cancer; RAD51C-related disorder; Familial ovarian cancer; Hereditary breast ovarian cancer syndrome | germline | 23 | Apr 13, 2026 | clinvar |